Journal of Jilin University Medicine Edition ›› 2015, Vol. 41 ›› Issue (01): 48-53.doi: 10.13481/j.1671-587x.20150110

Previous Articles     Next Articles

Effects of leptin on proliferation and apoptosis of breast carcinoma MCF-7 cells and its mechanism

LI Kuangfa, PANG Xueli, HUANG Yunxiu, WEI Lan, SU Min, CHEN Tingmei   

  1. Key Laboratory of Laboratory Medical Diagnostics, Ministry of Eduction, Chongqing Medical University, Chongqing 400016, China
  • Received:2013-10-25 Published:2015-01-30

Abstract:

Objective To observe the effects of leptin on the proliferation and apoptosis of the breast carcinoma MCF-7 cells, and to explore the mechanism. Methods The MCF-7 cells at logarithm growth phase were selected and randomly divided into control group and different doses (20, 40, 80 μg·L-1) of leptin groups.The proliferation rates of the MCF-7 cells in various groups were determined by CCK8 assay kit;the apoptotic rates of the MCF-7 cells in various groups were analyzed by flow cytometry;the mRNA and protein expressions of bcl-2 and bax of the MCF-7 cells in various groups were detected by RT-PCR and Western blotting methods;the protein expressions of p-AKT and bcl-2 in the MCF-7 cells in different cell signaling pathway inhibitor treatment groups were tested by Western blotting method. Results Compared with control group, the proliferation rates of the MCF-7 cells in leptin groups were increased in a dose-dependent manner(P<0.05);the apoptotic rates of the MCF-7 cells in leptin groups were decreased(P<0.05);the mRNA and protein expression levels of bax in the MCF-7 cells in leptin groups were decreased(P<0.05), and the mRNA and protein expression levels of bcl-2 were increased(P<0.05);compared with leptin group, the protein expressions of p-AKT and bcl-2 in PI3K-AKT inhibitor LY294002 group were markedly decreased(P<0.05). Conclusion Leptin can increase the proliferation and inhibit the apoptosis of breast carcinoma MCF-7 cells, and the mechanism of anti-apoptosis may be releted to the up-regulation of bcl-2 via PI3K-AKT signaling pathway.

Key words: leptin, breast carcinoma, apopotosis, signaling pathway

CLC Number: 

  • R392-33